Back to results
US 2016/0235829 A1Published application
Vectors for expression of prostate-associated antigens
AssigneePfizer Inc.
InventorJoseph John BINDER
Life of this patent
Estimating the term…
Abstract
The present disclosure provides (a) vectors comprising a multi-antigen construct encoding two, three, or more immunogenic PAA polypeptides; (b) compositions comprising the vectors, (c) methods relating to uses of the vectors and compositions for eliciting an immune response or for treating prostate cancers.
Claims21
1-24. (canceled)
A C68 vector comprising:
- (1) a C68 nucleotide sequence;
- and
- (2) a multi-antigen construct comprising at least two coding nucleotide sequences, wherein each of the two coding nucleotide sequences encodes an immunogenic PAA polypeptide selected from the group consisting of:
- (i) an immunogenic PSA polypeptide;
- (ii) an immunogenic PSCA polypeptide;
- and
- (iii) an immunogenic PSMA polypeptide.
4 more elements
Dependencies are inferred from the claim text.